{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T10:09:00Z","timestamp":1783937340822,"version":"3.55.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.contraception.2012.08.005","type":"journal-article","created":{"date-parts":[[2012,10,5]],"date-time":"2012-10-05T20:00:21Z","timestamp":1349467221000},"page":"567-575","source":"Crossref","is-referenced-by-count":20,"title":["Treatment of unscheduled bleeding in women using extended- or continuous-use combined hormonal contraception: a systematic review"],"prefix":"10.1016","volume":"87","author":[{"given":"Emily M.","family":"Godfrey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maura K.","family":"Whiteman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn M.","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2012.08.005_bb0005","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.contraception.2004.06.008","article-title":"Women's and providers' attitudes toward menstrual suppression with extended use of oral contraceptives","volume":"70","author":"Andrist","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.08.005_bb0010","author":"US Food and Drug Administration"},{"key":"10.1016\/j.contraception.2012.08.005_bb0020","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.contraception.2005.09.010","article-title":"Safety and efficacy of an extended-regimen oral contraceptive utilizing continuous low-dose ethinyl estradiol","volume":"73","author":"Anderson","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.08.005_bb0025","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.contraception.2006.07.005","article-title":"Evaluation of a continuous regimen of levonorgestrel\/ethinyl estradiol: phase 3 study results","volume":"74","author":"Archer","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.08.005_bb0030","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.contraception.2009.05.128","article-title":"Continuous, daily levonorgestrel\/ethinyl estradiol vs. 21-day, cyclic levonorgestrel\/ethinyl estradiol: efficacy, safety and bleeding in a randomized, open-label trial","volume":"80","author":"Teichmann","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.08.005_bb0035","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.contraception.2011.01.002","article-title":"Effect of extended-cycle regimen with an oral contraceptive containing 30 mcg ethinylestradiol and 2 mg dienogest on bleeding patterns, safety, acceptance and contraceptive efficacy","volume":"84","author":"Wiegratz","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.08.005_bb0040","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.contraception.2007.01.014","article-title":"Long-term assessment of symptomatology and satisfaction of an extended oral contraceptive regimen","volume":"75","author":"Coffee","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.08.005_bb0045","first-page":"CD004695","article-title":"Continuous or extended cycle vs. cyclic use of combined oral contraceptives for contraception","author":"Edelman","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.contraception.2012.08.005_bb0050","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.contraception.2005.06.068","article-title":"Yasmin Extended Regimen Study Group. The use of an oral contraceptive containing ethinylestradiol and drospirenone in an extended regimen over 126 days","volume":"73","author":"Foidart","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.08.005_bb0055","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.contraception.2009.05.004","article-title":"Extended regimens of the vaginal contraceptive ring: cycle control","volume":"80","author":"Guazzelli","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.08.005_bb0060","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/01.AOG.0000175144.08035.74","article-title":"Extended regimens of the contraceptive vaginal ring: a randomized trial","volume":"106","author":"Miller","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2012.08.005_bb0065","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1097\/01.AOG.0000160430.61799.f6","article-title":"Extended use of transdermal norelgestromin\/ethinyl estradiol: a randomized trial","volume":"105","author":"Stewart","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2012.08.005_bb0070","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/AOG.0b013e3181842071","article-title":"Frequency and management of breakthrough bleeding with continuous use of the transvaginal contraceptive ring: a randomized controlled trial","volume":"112","author":"Sulak","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2012.08.005_bb0075","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/S0015-0282(03)00794-5","article-title":"Continuous use of an oral contraceptive for endometriosis-associated recurrent dysmenorrhea that does not respond to a cyclic pill regimen","volume":"80","author":"Vercellini","year":"2003","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2012.08.005_bb0080","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1016\/j.fertnstert.2004.12.048","article-title":"Suppression of estrogen-withdrawal headache with extended transdermal contraception","volume":"83","author":"LaGuardia","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2012.08.005_bb0085","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1526-4610.2007.00650.x","article-title":"Headaches and oral contraceptives: impact of eliminating the standard 7-day placebo interval","volume":"47","author":"Sulak","year":"2007","journal-title":"Headache"},{"key":"10.1016\/j.contraception.2012.08.005_bb0090","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.contraception.2007.05.081","article-title":"Bleeding patterns associated with oral contraceptive use: a review of the literature","volume":"76","author":"Bachmann","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.08.005_bb0095","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.whi.2004.08.005","article-title":"Evidence about extending the duration of oral contraceptive use to suppress menstruation","volume":"14","author":"Hitchcock","year":"2004","journal-title":"Womens Health Issues"},{"key":"10.1016\/j.contraception.2012.08.005_bb0100","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S0029-7844(03)00014-0","article-title":"Continuous combination oral contraceptive pills to eliminate withdrawal bleeding: a randomized trial","volume":"101","author":"Miller","year":"2003","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2012.08.005_bb0105","series-title":"Selected practice recommendations for contraception use","author":"World Health Organization","year":"2004"},{"key":"10.1016\/j.contraception.2012.08.005_bb0110","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S1701-2163(16)32526-9","article-title":"Canadian consensus guideline on continuous and extended hormonal contraception, 2007","volume":"29","author":"Guilbert","year":"2007","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.contraception.2012.08.005_bb0115","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.amepre.2005.02.008","article-title":"Keeping up with evidence: a new system for WHO's evidence-based family planning guidance","volume":"28","author":"Mohllajee","year":"2005","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.contraception.2012.08.005_bb0120","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0749-3797(01)00261-6","article-title":"Current methods of the US Preventive Services Task Force: a review of the process","volume":"20","author":"Harris","year":"2001","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.contraception.2012.08.005_bb0125","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1097\/AOG.0b013e3181e0119c","article-title":"Treatment of unscheduled bleeding in continuous oral contraceptive users with doxycycline: a randomized controlled trial","volume":"115","author":"Kaneshiro","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2012.08.005_bb0130","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.ajog.2006.02.048","article-title":"Prospective analysis of occurrence and management of breakthrough bleeding during an extended oral contraceptive regimen","volume":"195","author":"Sulak","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2012.08.005_bb0135","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.contraception.2011.08.006","article-title":"A randomized controlled trial of subantimicrobial-dose doxycycline to prevent unscheduled bleeding with continuous oral contraceptive pill use","volume":"85","author":"Kaneshiro","year":"2012","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.08.005_bb0140","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1093\/humrep\/del206","article-title":"Doxycycline alters the expression of inflammatory and immune-related cytokines and chemokines in human endometrial cells: implication in irregular uterine bleeding","volume":"21","author":"Li","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2012.08.005_bb0150","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.contraception.2011.11.003","article-title":"Unscheduled bleeding with continuous oral contraceptive pills: a comparison of progestin dose","volume":"86","author":"Kaneshiro","year":"2012","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.08.005_bb0155","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1097\/01.AOG.0000199950.64545.16","article-title":"Continuous oral contraceptives: are bleeding patterns dependent on the hormones given?","volume":"107","author":"Edelman","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2012.08.005_bb0160","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.contraception.2008.11.011","article-title":"Adding low-dose estrogen to the hormone-free interval: impact on bleeding patterns in users of a 91-day extended regimen oral contraceptive","volume":"79","author":"Kaunitz","year":"2009","journal-title":"Contraception"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782412007329?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782412007329?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T04:22:20Z","timestamp":1542687740000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782412007329"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S0010782412007329"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2012.08.005","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]}}}